BTR Capital Management Inc. boosted its position in UnitedHealth Group Inc (NYSE:UNH) by 0.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 39,082 shares of the healthcare conglomerate’s stock after purchasing an additional 354 shares during the quarter. UnitedHealth Group comprises 2.0% of BTR Capital Management Inc.’s holdings, making the stock its 17th biggest position. BTR Capital Management Inc.’s holdings in UnitedHealth Group were worth $11,489,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of UNH. Eagle Capital Management LLC grew its stake in shares of UnitedHealth Group by 0.9% in the second quarter. Eagle Capital Management LLC now owns 16,213 shares of the healthcare conglomerate’s stock valued at $3,956,000 after buying an additional 147 shares in the last quarter. Pictet Asset Management Ltd. lifted its stake in shares of UnitedHealth Group by 1.5% in the second quarter. Pictet Asset Management Ltd. now owns 952,651 shares of the healthcare conglomerate’s stock worth $232,456,000 after acquiring an additional 14,369 shares during the period. Gladstone Institutional Advisory LLC acquired a new position in shares of UnitedHealth Group in the second quarter worth approximately $379,000. Assetmark Inc. lifted its stake in shares of UnitedHealth Group by 219.8% in the second quarter. Assetmark Inc. now owns 91,533 shares of the healthcare conglomerate’s stock worth $22,335,000 after acquiring an additional 62,914 shares during the period. Finally, Baker Avenue Asset Management LP lifted its stake in shares of UnitedHealth Group by 41.1% in the second quarter. Baker Avenue Asset Management LP now owns 7,542 shares of the healthcare conglomerate’s stock worth $1,840,000 after acquiring an additional 2,198 shares during the period. Hedge funds and other institutional investors own 85.44% of the company’s stock.
In related news, EVP D Ellen Wilson sold 7,400 shares of the company’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $272.77, for a total transaction of $2,018,498.00. Also, CAO Thomas E. Roos sold 1,177 shares of the company’s stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $255.04, for a total value of $300,182.08. Following the sale, the chief accounting officer now owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The disclosure for this sale can be found here. 0.87% of the stock is owned by corporate insiders.
A number of research firms recently commented on UNH. Mizuho reaffirmed a “buy” rating and issued a $300.00 price objective (up from $270.00) on shares of UnitedHealth Group in a research note on Tuesday, November 26th. Jefferies Financial Group lowered UnitedHealth Group from a “buy” rating to a “hold” rating and cut their price objective for the stock from $300.00 to $235.00 in a research note on Thursday, October 10th. Stephens lifted their price objective on UnitedHealth Group from $325.00 to $333.00 and gave the stock an “overweight” rating in a research note on Wednesday. BMO Capital Markets reaffirmed a “market perform” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, December 4th. Finally, Wells Fargo & Co reaffirmed an “overweight” rating and issued a $335.00 price objective (up from $318.00) on shares of UnitedHealth Group in a research note on Wednesday, December 11th. Five equities research analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $313.50.
Shares of NYSE:UNH traded down $2.93 during trading on Friday, reaching $297.81. 35,016 shares of the stock were exchanged, compared to its average volume of 3,851,768. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.70 and a quick ratio of 0.70. UnitedHealth Group Inc has a 1-year low of $208.07 and a 1-year high of $300.99. The stock has a fifty day moving average of $288.85 and a two-hundred day moving average of $255.32. The firm has a market cap of $273.08 billion, a price-to-earnings ratio of 23.14, a price-to-earnings-growth ratio of 1.37 and a beta of 0.65.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Wednesday, January 15th. The healthcare conglomerate reported $3.90 earnings per share for the quarter, topping analysts’ consensus estimates of $3.77 by $0.13. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The company had revenue of $60.90 billion for the quarter, compared to analyst estimates of $61.17 billion. During the same period in the prior year, the firm earned $3.28 earnings per share. UnitedHealth Group’s revenue for the quarter was up 4.3% on a year-over-year basis. Sell-side analysts forecast that UnitedHealth Group Inc will post 14.98 EPS for the current year.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.